据欧盟网站消息，6月16日欧盟委员会及其新兴鉴定健康风险科学委员会（SCENIHR） 发布银纳米颗粒对安全、健康和环境影响以及耐药性作用的最终意见。
该意见旨在评估与传统银相比，纳米银的使用与是否会导致额外的风险，尤其是在医疗保健和消费品中。以及纳米银用于控制细菌生长时，是否会导致微生物的耐药性。
欧盟委员会称，考虑到银纳米粒子在使用时可能产生的耐药性问题，因此有必要获取更多的有关病菌对阴离子与银纳米粒子反应的数据。
部分原文报道如下：
Today, the European Commission and its non-food Scientific Committee on Emerging and Newly Identified Health Risks, SCENIHR, published the final opinion on “Nanosilver: safety, health and environmental effects and role in antimicrobial resistance”.
The aim of this opinion is to assess whether the use of nanosilver, in particular in medical care and in consumer products, could result in additional risks compared to more traditional uses of silver and whether the use of nanosilver to control bacterial growth could result in resistance of micro-organisms.
Regarding the hazard associated with the dissemination of the resistance mechanism following the use of silver nanoparticles, more data are needed to better understand bacterial response to ionic silver and silver nanoparticles exposure.
原文链接：http://ec.europa.eu/dgs/health_consumer/dyna/enews/enews.cfm?al_id=1494
日期：2014-06-20
